BioSpace News Archive

Chroma Medicine debuted Wednesday morning with $125 million in seed and Series A funding.

Innate Pharma SA announced its revenues and cash position for the first nine months of 2021.

Basilea Pharmaceutica Ltd., a commercial-stage biopharmaceutical company committed to meeting the needs of patients with cancer and infectious diseases, announced that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration, to start clinical studies with the company’s novel drug candidate BAL0891 in cancer therapy.

Transparency Market Research has published a new report titled, “Urinary Incontinence Treatment Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Clinical and hospital laboratories presently account for a massive chunk of the total number of diagnostic, monitoring or screening tests undertaken across the globe.

Transparency Market Research has published a new report titled, Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

November 16, 2021, 7:30 a.m. CET - OSE Immunotherapeutics SA presented new clinical and translational data on Tedopi® in non-small cell lung cancer and the latest data from BiCKI®-IL-7 preclinical programs at the Society for Immunotherapy of Cancer 36th Annual Meeting in Washington D.C. held on November 10 – 14, 2021.

The global medical radiation shielding market is expected to grow at a positive rate between 2017 and 2025.

SanBio Company Limited hereby announces that it entered into a business partnership agreement with D&P Bioinnovations, Inc., a US-based regenerative medicine company, regarding the development and commercialization of a medical device implant utilizing the Company’s regenerative medicine MSC2 for the regeneration of esophageal tissue in humans on November 15, 2021.

American CryoStem Corporation, a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced that it has completed the development of a new standardized wound healing protocol utilizing its tissue based technologies with Advanced Regenerative Associates.